Prediction: Eli Lilly's Newest GLP-1 Drug Will Be a Game-Changer for the Stock [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
newest GLP-1 drug had successfully completed the first of several phase 3 drug trials. The jump in share price propelled the stock into positive territory -- it was up nearly 9% year to date as of this writing, and up about 12% over the past 12 months. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Let's look at why this news could be a game-changer for Eli Lilly and its stock. The successful phase 3 trial for Lilly's orforglipron brings the drug one step closer to being approved by the U.S. Food and Drug Administration (FDA). The first successful Achieve-1 study was done to evaluate the safety and efficacy of the drug in treating patients with type 2 diabetes. Several other Achieve phase 3 trials are being conducted, as well as several Attain trials examining the drug's usefulness in treating obese patients or overweight patients with at least one other underlying condition, such as hypert
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Healthy Returns: 2026 will be the year of obesity pills from Novo Nordisk, Eli Lilly [CNBC]CNBC
- Is Eli Lilly a Buy Before 2026? [Yahoo! Finance]Yahoo! Finance
- Lilly to participate in J.P. Morgan Healthcare ConferencePR Newswire
- Eli Lilly and Company (NYSE:LLY) was given a new $1,230.00 price target on by analysts at Daiwa Capital Markets. They now have a "buy" rating on the stock.MarketBeat
- Where Will Eli Lilly Be in 10 Years? [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 10/30/25 - Beat
LLY
Sec Filings
- 12/16/25 - Form 4
- 12/16/25 - Form 4
- 12/16/25 - Form 4
- LLY's page on the SEC website